Characterization of CD34+ Hematopoietic Progenitor Cells in JAK2 V617F and CALR -Mutated Myeloproliferative Neoplasms

Leukemia Research - United Kingdom
doi 10.1016/j.leukres.2016.06.009
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

JAK2, CALR, and MPL Mutation Spectrum in Japanese Patients With Myeloproliferative Neoplasms

Haematologica
Hematology
2014English

Myeloproliferative Neoplasms Can Be Initiated From a Single Hematopoietic Stem Cell expressingJAK2-V617F

Journal of Experimental Medicine
MedicineAllergyImmunology
2014English

JAK2 and MPL Mutations in Myeloproliferative Neoplasms: Discovery and Science

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2008English

Role of Mesenchymal Stromal Cells and Their Extracellular Vesicles microRNAs in JAK2 Myeloproliferative Neoplasms

English

JAK2 Exon 14 Deletion in Patients With Chronic Myeloproliferative Neoplasms

PLoS ONE
Multidisciplinary
2010English

JAK2 Exon 12 Mutated Polycythemia Vera: Mayo-Careggi MPN Alliance Study of 33 Consecutive Cases and Comparison With JAK2 V617F Mutated Disease

American Journal of Hematology
Hematology
2018English

Role of CD34 Antigen in Myeloid Differentiation of Human Hematopoietic Progenitor Cells

Stem Cells
MedicineMolecular MedicineDevelopmental BiologyCell Biology
2008English

The Role of the JAK2 GGCC Haplotype and the TET2 Gene in Familial Myeloproliferative Neoplasms

Haematologica
Hematology
2010English

Molecular Drug Targets in Myeloproliferative Neoplasms: Mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy